Skip to main content

JPMORGAN CHASE & CO

Position in PCVX — Vaxcyte, Inc.

CIK 19617 NEW YORK, NY

Position in PCVX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$71,345,621
+$12,752,498 QoQ
Shares Held
1,227,346
+21.7% QoQ
Ownership
0.825%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. PCVX ranks #21 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,345,621 1,227,346
2026-03-31 $58,593,123 1,008,314
2025-12-31 $50,085,843 1,085,519
2025-09-30 $56,372,593 1,565,036
2025-06-30 $38,972,008 1,198,770
2025-03-31 $71,750,756 1,900,179
2024-12-31 $142,081,369 1,735,663
2024-09-30 $163,150,132 1,427,760
2024-06-30 $91,551,567 1,212,443
2024-03-31 $79,360,985 1,161,777
2023-12-31 $25,454,974 405,334
2023-09-30 $32,511,013 637,721
2023-06-30 $17,799,061 356,409
2023-03-31 $10,977,739 292,896
2022-12-31 $12,128,088 252,932
2022-09-30 $4,323,048 180,127
2022-06-30 $961,181 44,172
2022-03-31 $647,025 26,792
2021-12-31 $485,362 20,402
2021-09-30 $661,065 26,057
2021-06-30 $492,540 21,881
2021-03-31 $1,282,663 64,945
2020-12-31 $996,134 37,491
2020-09-30 $335,191 6,788